|
|
"Cancer Information Service"
|
N02CO511014-003
|
$653,527
|
$65,353
|
ISSELL, BRIAN
|
University of Hawaii
|
|
|
"Cancer Information Service"
|
N02CO511000-003
|
$961,822
|
$96,182
|
DEVITA, VINCENT
|
Yale University Inc
|
|
|
"Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C
|
Z01 CP010153
|
$696,133
|
$17,151
|
Ward
|
DCEG (NCI)
|
|
|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
$21,148
|
Engels
|
DCEG (NCI)
|
|
|
A Behavioral Economic Approach to Smoking Cessation
|
5R01CA096836-05
|
$173,816
|
$165,125
|
AUDRAIN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-14
|
$1,647,107
|
$247,066
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Microfluidic Platform for Early Detection and Prognostication of Cancer
|
1R03CA132189-01
|
$54,000
|
$54,000
|
Wheeler, Aaron
|
UNIVERSITY OF TORONTO
|
|
|
A Molecular Basis for Neuroendocrine Carcinogenesis
|
5R01CA112405-03
|
$233,253
|
$233,253
|
GRIMES, H
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
A mouse model of stem cell deregulation and lung cancer
|
2R01CA076354-07A2
|
$264,921
|
$264,921
|
LOCKER, JOSEPH
|
YESHIVA UNIVERSITY
|
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
1R01CA125231-01A1
|
$552,813
|
$88,450
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
A Phase 2 Trial of Dasatinib in Patients with NSCLC and Acquired Resistance to Er
|
1R21CA130343-01
|
$226,200
|
$226,200
|
MILLER, VINCENT
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
A Phase I Trial of CCL-21 Gene Modified DC in NSCLC
|
5R21CA105705-02
|
$331,634
|
$331,634
|
Dubinett, Steven
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
A Pilot Smoking Cessation Study for Newly Diagnosed Lung Cancer Patients
|
1R03CA130722-01
|
$87,500
|
$87,500
|
PARK, ELYSE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
A Simulation of Tobacco Policy, Smoking and Lung Cancer
|
5U01CA097450-06
|
$308,713
|
$308,713
|
LEVY, DAVID
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
|
A Tumor Specific Therapy Approach for Small Cell Lung Cancer
|
5R21CA104297-02
|
$122,501
|
$122,501
|
ZOU, YIYU
|
YESHIVA UNIVERSITY
|
|
|
A Web-Based Smoking Intervention for Cancer Survivors
|
5R01CA106914-04
|
$558,648
|
$530,716
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
|
ABC Transporters in Human Disease and Multidrug Resistance
|
Z01 BC 005725
|
$505,750
|
$50,575
|
Dean, Michael
|
CCR (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
$19,367
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
$655,409
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Accurate Models for Predicting Radiation-Induced Injury
|
5R01CA115748-02
|
$226,684
|
$113,342
|
DAS, SHIVA
|
DUKE UNIVERSITY
|
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-03
|
$555,262
|
$111,052
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
|
Activation of checkpoint pathways in cancer
|
5R01CA118827-02
|
$186,141
|
$186,141
|
Halazonetis, Thanos
|
UNIVERSITY OF GENEVA
|
|
|
Addressing Parental Smoking by Changing Pediatric Office Systems
|
1R01CA127127-01
|
$620,907
|
$589,862
|
WINICKOFF, JONATHAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Adenocarcinoma of the Lung: role of NNK susceptibility
|
5R01CA055769-17
|
$642,351
|
$642,351
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Adolescent Smoking Cessation in Pediatric Primary Care
|
5R21CA122705-02
|
$150,747
|
$143,210
|
KLEIN, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
Advanced Anatomic and Functional Response Assessment in Lung Cancer
|
1R01CA125143-01A1
|
$354,322
|
$354,322
|
SCHWARTZ, LAWRENCE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Aerosol Therapy for Lung Cancer
|
5R44CA096409-03
|
$371,115
|
$371,115
|
Hansen, Brian
|
AEROPHASE, INC.
|
|
|
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer
|
1R01CA124640-01
|
$308,750
|
$308,750
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Aldo-Keto Reductases and PAH Metabolism/Activation
|
5R01CA039504-22
|
$282,539
|
$282,539
|
Penning, Trevor
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Alpha-1 AD Carriers and Lung Cancer Risk
|
5R01CA080127-07
|
$524,983
|
$524,983
|
YANG, PING
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
$1,329,700
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Surgeons Oncology Group
|
3U10CA076001-11S1
|
$300,000
|
$30,000
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
|
American College of Surgeons Oncology Group
|
5U10CA076001-11
|
$3,000,000
|
$300,000
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
|
American/Australian Mesothelioma Consortium
|
5U01CA111295-03
|
$433,230
|
$433,230
|
PASS, HARVEY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
An exploratory study to integrate cell phones into RDD health surveys
|
1R21CA129474-01
|
$286,827
|
$286,827
|
DELNEVO, CRISTINE
|
UNIV OF MED/DENT NJ-SCH OF PUBLIC HEALTH
|
|
|
An Innovative Telephone Intervention for HIV+ Smokers
|
5R01CA097893-02
|
$507,651
|
$482,268
|
GRITZ, ELLEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
1R01CA124648-01
|
$416,058
|
$41,606
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
|
Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Mal
|
Z01 BC 005445
|
$687,001
|
$27,480
|
Yuspa, Stuart
|
CCR (NCI)
|
|
|
Analysis of Tobacco Industry Documents
|
5R01CA087472-08
|
$646,421
|
$549,458
|
GLANTZ, STANTON
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-03
|
$283,140
|
$268,983
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
|
Animal Model for Her-2/neu Specific TCR Gene Transfer
|
5R01CA102280-06
|
$263,355
|
$65,839
|
NISHIMURA, MICHAEL
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
ANTIBODY ARRAY FOR EARLY DETECTION OF LUNG CANCER
|
N43CN700041-000
|
$145,089
|
$145,089
|
STENGELIN, MARTIN
|
MESO SCALE DIAGNOSTICS, LLC
|
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
2P01CA043904-16A1
|
$2,922,793
|
$730,698
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,324,087
|
$132,409
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
Antitumor Mechanisms of SRC Inhibitors in Lung Cancer
|
1R01CA123174-01A1
|
$309,700
|
$309,700
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-21
|
$360,308
|
$54,046
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Appalachia Community Cancer Network
|
5U01CA114622-03
|
$1,001,201
|
$330,396
|
Dignan, Mark
|
UNIVERSITY OF KENTUCKY
|
|
|
Arginase Production in Cancer: Evading Immune Response
|
5R01CA107974-04
|
$276,017
|
$69,004
|
OCHOA, AUGUSTO
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
$7,266
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
$2,265
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Total relevant funding to Lung for this search: $226,892,485
|
